Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2020.
| Egile nagusia: | |
|---|---|
| Beste egile batzuk: | |
| Formatua: | Internship report |
| Hizkuntza: | English |
| Argitaratua: |
Brac University
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | http://hdl.handle.net/10361/15130 |
| id |
10361-15130 |
|---|---|
| record_format |
dspace |
| spelling |
10361-151302021-10-04T21:01:31Z Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited Sadik, Khondaker Yaseer Alam, Syed Mahfujul Brac Business School, Brac University GlaxoSmithKline Plc. Limited Risk management Pharmaceuticals Risk management. This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2020. Cataloged from PDF version of internship report. Includes bibliographical references (page 29). GlaxoSmithKline Plc. Limited has a purpose to “Improve the quality of human life by enabling people to do more, feel better and live longer.” The company adapts a centralized Risk Management Framework and Corporate Governance practice that are followed by all its subsidiaries. This research paper focuses on how GSK monitors, maintains and mitigates its risks based on the prescribed guidelines. Further, it also states the effectiveness of the company’s Enterprise Risk Management practices. The company focuses heavily on its product quality, financial control and reporting, Anti-bribery & corruption and Third party oversight. GlaxoSmithKline Bangladesh Limited maintains a moderate level of risk by maintain the same standards and procedures that are followed by GlaxoSmithKline Limited internationally. Taking all factors into consideration this paper evaluates GSK should take a more local approach to thrive in Bangladesh’s market and the issues that are related to the closure of the pharmaceutical business unit. Khondaker Yaseer Sadik B. Business Administration 2021-10-04T05:36:06Z 2021-10-04T05:36:06Z 2020 2020-04 Internship report ID 16104151 http://hdl.handle.net/10361/15130 en Brac University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 29 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
GlaxoSmithKline Plc. Limited Risk management Pharmaceuticals Risk management. |
| spellingShingle |
GlaxoSmithKline Plc. Limited Risk management Pharmaceuticals Risk management. Sadik, Khondaker Yaseer Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited |
| description |
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2020. |
| author2 |
Alam, Syed Mahfujul |
| author_facet |
Alam, Syed Mahfujul Sadik, Khondaker Yaseer |
| format |
Internship report |
| author |
Sadik, Khondaker Yaseer |
| author_sort |
Sadik, Khondaker Yaseer |
| title |
Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited |
| title_short |
Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited |
| title_full |
Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited |
| title_fullStr |
Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited |
| title_full_unstemmed |
Enterprise risk management analysis of GlaxoSmithKline Bangladesh Limited |
| title_sort |
enterprise risk management analysis of glaxosmithkline bangladesh limited |
| publisher |
Brac University |
| publishDate |
2021 |
| url |
http://hdl.handle.net/10361/15130 |
| work_keys_str_mv |
AT sadikkhondakeryaseer enterpriseriskmanagementanalysisofglaxosmithklinebangladeshlimited |
| _version_ |
1814306925558366208 |